Scarica l'app Stockscreener
1.69
0.59%
-0.01
Precedente Chiudi:
$1.70
Aprire:
$1.67
Volume 24 ore:
4.76M
Relative Volume:
2.91
Capitalizzazione di mercato:
$324.77M
Reddito:
$206.13M
Utile/perdita netta:
$-15.64M
Rapporto P/E:
-20.48
EPS:
-0.0825
Flusso di cassa netto:
$1.11M
1 W Prestazione:
-12.44%
1M Prestazione:
-24.55%
6M Prestazione:
+37.40%
1 anno Prestazione:
+21.58%
Intervallo 1D:
$1.625
$1.735
Intervallo di 1 settimana:
$1.62
$1.96
Portata 52W:
$1.12
$2.955
Cerus Corp Stock (CERS) Company Profile
Nome
Cerus Corp
Settore
Industria
Telefono
(925) 288-6000
Indirizzo
1220 CONCORD AVENUE, CONCORD, CA
Compare CERS vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
CERS
Cerus Corp
|
1.69 | 324.77M | 206.13M | -15.64M | 1.11M | -0.0825 |
|
ABT
Abbott Laboratories
|
108.03 | 187.72B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
336.77 | 128.88B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
87.14 | 111.88B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.13 | 102.58B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
81.81 | 47.52B | 6.07B | 1.06B | 1.34B | 1.8063 |
Cerus Corp Stock (CERS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-04-12 | Iniziato | Craig Hallum | Buy |
| 2023-01-20 | Downgrade | BTIG Research | Buy → Neutral |
| 2023-01-17 | Downgrade | Stephens | Overweight → Equal-Weight |
| 2020-10-08 | Ripresa | BTIG Research | Buy |
| 2020-06-16 | Ripresa | Cantor Fitzgerald | Overweight |
| 2020-02-26 | Iniziato | BTIG Research | Buy |
| 2019-11-13 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2019-08-28 | Iniziato | Stifel | Buy |
| 2019-08-23 | Ripresa | Stephens | Overweight |
| 2018-01-05 | Ripresa | Cantor Fitzgerald | Overweight |
| 2017-12-08 | Ripresa | BTIG Research | Neutral |
| 2016-07-07 | Ripresa | Cantor Fitzgerald | Buy |
| 2015-12-17 | Downgrade | Wedbush | Outperform → Neutral |
| 2014-05-02 | Reiterato | MLV & Co | Buy |
| 2013-04-24 | Reiterato | Cantor Fitzgerald | Buy |
| 2013-03-15 | Reiterato | MLV & Co | Buy |
| 2012-04-17 | Iniziato | Cantor Fitzgerald | Buy |
| 2012-02-29 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2011-11-10 | Reiterato | MLV & Co | Buy |
| 2011-06-03 | Iniziato | Wedbush | Outperform |
| 2011-03-04 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2010-03-09 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2009-08-26 | Aggiornamento | Avondale | Mkt Perform → Mkt Outperform |
Mostra tutto
Cerus Corp Borsa (CERS) Ultime notizie
Cerus (NASDAQ:CERS) Lowered to "Strong Sell" Rating by Zacks Research - MarketBeat
Greenman, Cerus Corp president, sells $156k in CERS stock By Investing.com - Investing.com Nigeria
Cerus CFO Kevin Green sells $169k in shares By Investing.com - Investing.com India
Cerus CFO Kevin Green sells $169k in shares - Investing.com
Cerus (NASDAQ:CERS) CFO Kevin Dennis Green Sells 55,225 Shares - MarketBeat
Cerus corp chief medical officer sells shares worth $250k By Investing.com - Investing.com South Africa
Cerus corp chief medical officer sells shares worth $250k - Investing.com
Cerus (CERS) CMO sells 125,894 shares, receives 55,220-share grant - Stock Titan
Cerus CFO Kevin Green sells $169k in CERS stock By Investing.com - Investing.com Australia
Cerus CFO Kevin Green sells $169k in CERS stock - Investing.com Australia
Cerus (NASDAQ:CERS) CFO Kevin Dennis Green Sells 27,796 Shares - MarketBeat
Richard Benjamin Sells 61,233 Shares of Cerus (NASDAQ:CERS) Stock - MarketBeat
Cerus Corp chief medical officer sells shares worth $202k By Investing.com - Investing.com South Africa
Cerus (CERS) CFO mixes stock award with planned and tax-driven sales - Stock Titan
Cerus Corp chief medical officer sells shares worth $202k - Investing.com
Cerus Corp chief legal officer Jensen sells $61,859 in stock - Investing.com
Cerus Corp chief legal officer Jensen sells $61,859 in stock By Investing.com - Investing.com Nigeria
Cerus Corp COO Jayaraman sells $68k in shares By Investing.com - Investing.com Canada
Cerus Corp COO Jayaraman sells $68k in shares - Investing.com
Greenman, Cerus Corp president, sells $156k in CERS stock - Investing.com
CERUS (CERS) CEO gets 193k-share grant, sells 78k shares to cover tax withholding - Stock Titan
Richard J. Benjamin sells 61,233 and 24,235 CERS shares (NASDAQ: CERS) - Stock Titan
Cerus Details INTERCEPT Growth Plan, BCA Deal Upside and 2026 RBC Milestones at TD Cowen Conference - Yahoo Finance
Cerus (NASDAQ:CERS) Stock Rating Lowered by Wall Street Zen - MarketBeat
Cathie Wood's ARK Investment Acquires Shares in Cerus (CERS) - GuruFocus
Morgan Stanley files Form 144 listing CERS restricted-share notices (CERS) - Stock Titan
Cerus (CERS) awards 264,000 restricted stock units to its CMO - Stock Titan
CERS Earnings History & Surprises | EPS & Revenue Results | CERUS CORP (NASDAQ:CERS) - ChartMill
Cerus Corporation (NASDAQ:CERS) Q4 2025 Earnings Call Transcript - Insider Monkey
Cerus (CERS) Revenue Growth Outpaces Market And Reinforces Bullish Margin Recovery Narrative - simplywall.st
Cerus at TD Cowen Conference: Strategic Growth in Blood Transfusion - Investing.com South Africa
$CERS stock is down 16% today. Here's what we see in our data. - Quiver Quantitative
Cerus Corporation Q4 2025 Earnings Call Summary - Yahoo Finance
MongoDB, Surgery Partners, Harrow And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Cerus Corp (CERS) Q4 2025 Earnings Call Highlights: Record Reven - GuruFocus
Cerus Corporation 2025 Annual Report: INTERCEPT Blood System, Product Pipeline, and Regulatory Updates - Minichart
Cerus: Q4 Earnings Snapshot - theheraldreview.com
Cerus Corp reports results for the quarter ended December 31Earnings Summary - TradingView
Cerus Q4 Earnings Call Highlights - Yahoo Finance
Cerus Corp (NASDAQ:CERS) Reports Mixed Q4 2025 Results, Stock Falls on Revenue Miss - ChartMill
Cerus: Q4 Financial Results Overview - Bitget
Earnings call transcript: Cerus Corporation Q4 2025 exceeds revenue expectations - Investing.com
Cerus (NASDAQ:CERS) Posts Quarterly Earnings Results, Hits Expectations - MarketBeat
Cerus 10-K: Revenue $233.8M, product growth drives results - TradingView
Cerus (NASDAQ: CERS) outlines INTERCEPT blood system pipeline - Stock Titan
CERS Forecasts Growth in 2026 Product Revenue - GuruFocus
Cerus Corporation (CERS) Stock Rises on Q4 2025 Earnings - Quiver Quantitative
Cerus falls 7% after posting in-line Q4 earnings, revenue beat - Investing.com South Africa
12 Health Care Stocks Moving In Monday's After-Market Session - Benzinga
Cerus Q4 Earnings Assessment - Benzinga
Cerus (Nasdaq: CERS) grows 2025 revenue 16% and reaffirms 2026 outlook - Stock Titan
Cerus Corp Azioni (CERS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.66%
1.56%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):